written on 28.03.2014

Critics knock JAMA study linking testosterone drugs to cardio risks


A study the FDA has cited as a reason to investigate the cardiovascular safety of testosterone drugs has come under heavy fire from critics. Physicians and researchers are calling for the November paper's retraction, citing at least two corrections that they say compromise its credibility.